Clinical Trials in Baltimore

Showing 16701-16720 of 23,476 trials

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

NCT02202161

This study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2330672 compared to sitagliptin when administered with metformin for 14 days to subjects with type 2 diabetes mellitus (T2DM). Approximately 72 male and female subjects aged 30-64 years with T2DM and currently taking metformin will be recruited for this study. Eligible subjects will begin a run-in period of 13-15 days to stabilize on metformin 850 milligram (mg) twice a day (BID). Subjects will then be randomized to GSK2330672 10 mg, 20 mg, 30 mg, 90 mg, matching placebo or open-label sitagliptin 50 mg for 14 days BID. Subjects will return for a follow-up visit 7-10 days after discharge.

Diabetes Mellitus, Type 2

GlaxoSmithKline70 participantsStarted Aug 2014

Chula Vista, California, United States • Miami, Florida, United States • Baltimore, Maryland, United States +1 more locations

COMPLETEDPhase 3< 1 mile

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

NCT01732822

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

Peripheral Artery Disease

AstraZeneca13,885 participantsStarted Dec 2012

Alexander City, Alabama, United States • Auburn, Alabama, United States • Birmingham, Alabama, United States +773 more locations

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Find Trials by Condition in Baltimore

Treatment for Men Who Are Abusive to Their Partners

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

F-18 Sodium Fluoride in Prostate Cancer

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Technical Development of Cardiovascular Magnetic Resonance Imaging

PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Ablation of Intestinal Metaplasia Containing Dysplasia

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Depression and Health Outcomes in Refractory Epilepsy

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy